Rediema Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

rediema

idelyn s.r.o. - iné antidepresíva - 92 - tradiČnÉ rastlinnÉ lieky

Braftovi Европейски съюз - словашки - EMA (European Medicines Agency)

braftovi

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastické činidlá - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.